OrangeNXT is part of ICT Group and focuses on asset management, cognitive search, and quality assessment. Their services aim to facilitate digital innovation and provide customer-oriented solutions.

OrangeNXT

Axonius provides a platform that aggregates, normalizes, and correlates asset data from various sources to offer a comprehensive inventory, uncover gaps, and automate response actions. It helps customers understand their digital infrastructure, make business-level decisions, inform strategy, mitigate threats, navigate risk, and accelerate incident response.

Ofri Shur

Dean Sysman

Avidor Bartov

Axonius

BrainCheck provides digital neurocognitive testing and care plans, facilitating cognitive health assessment and management.

BrainCheck

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IIV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments?on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Metric
Company Name	OrangeNXT	Axonius	BrainCheck	Cambridge Cognition Holdings Plc
Symbol				COG
MSH ID	COM:ORANGENXT	COM:AXONIUS	COM:BRAINCHECK	COM:CAMBRIDGECOGNITION
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Technology	Technology	Healthcare & Health Services	Healthcare
Industry	Information Technology	Cybersecurity	Health Technology	Medical - Healthcare Information Services
Country	NL	US	US	GB
Stage		Series E
Employee Count		583		119
Website	orangenxt.com	axonius.com	braincheck.com	cambridgecognition.com
LinkedIn		axonius
Founders

Metric
Market Cap	2.80B	180.77K
Enterprise Value
Monthly Web Traffic	44.72K
Web Traffic Growth	0.31
Valuation
Raised Capital	200M

Metric
Revenue				17.41M
Revenue (LTM)
Revenue (NTM)
Gross Profit				13.19M
EBITDA				-1.90M
Operating Income				-2.76M
Net Income				-4.52M
EPS				-0.13
Diluted EPS				-0.13
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.81
Operating Profit Margin				-0.02
EBITDA Margin				-0.11
Net Profit Margin				-0.10
Return on Equity				-0.69
Return on Assets				-0.09
Return on Capital Employed				-0.06

ORAN

COM:ORANGENXT

OrangeNXT

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-40.17
P/B Ratio				172.94
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				1.54
EV Multiple				49.13

Metric
Days Sales Outstanding
Days Payables Outstanding				1.66K
Days Inventory Outstanding				27.28
Operating Cycle				135.97
Cash Conversion Cycle				-201.71
Asset Turnover				0.95

Metric
Operating Cash Flow				-6.52M
Free Cash Flow				-6.56M
Cash Flow to Debt				0.34
Operating Cash Flow/Sales				-0.24
Free Cash Flow Yield				0.08

Metric
Cash & Equivalents				4.15M
Accounts Receivable				2.88M
Inventory				240.94K
Goodwill
Debt to Capitalization				1.11
Debt to Assets				0.00
Current Ratio				0.90
Quick Ratio				0.63

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue
SG&A to Revenue				0.76